Correlation Between Cingulate Warrants and Spero Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cingulate Warrants and Spero Therapeutics, you can compare the effects of market volatilities on Cingulate Warrants and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Spero Therapeutics.

Diversification Opportunities for Cingulate Warrants and Spero Therapeutics

0.52

Correlation Coefficient

Cingulate Warrants  Spero Therapeutics

Very weak diversification

The 3 months correlation between Cingulate and Spero is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Spero Therapeutics go up and down completely randomly.

Pair Corralation between Cingulate Warrants and Spero Therapeutics

Assuming the 90 days horizon Cingulate Warrants is expected to generate 6.15 times more return on investment than Spero Therapeutics. However, Cingulate Warrants is 6.15 times more volatile than Spero Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Spero Therapeutics is currently generating about -0.09 per unit of risk. If you would invest  6.75  in Cingulate Warrants on September 12, 2024 and sell it today you would lose (3.12) from holding Cingulate Warrants or give up 46.22% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.44%
Values	Daily Returns

Cingulate Warrants  vs.  Spero Therapeutics

Cingulate Warrants

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cingulate Warrants has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly weak technical and fundamental indicators, Cingulate Warrants may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Spero Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spero Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Cingulate Warrants and Spero Therapeutics

The main advantage of trading using opposite Cingulate Warrants and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.

The idea behind Cingulate Warrants and Spero Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.